AHA/BHA and the Skin Barrier

The Corneodesmosome-Degradation Mechanism

Kornhauser, Coelho, and Hearing's foundational research on hydroxy acid applications provides the mechanistic basis for understanding both AHA and BHA's shared underlying mechanism — degrading the corneodesmosomes responsible for corneocyte adhesion, facilitating the desquamation process central to their exfoliation function, a mechanism directly relevant to, though distinct from, the lipid-focused barrier structure discussed extensively throughout this literature's ceramide reviews.^[5]

Documented Structural Benefit Beyond Simple Exfoliation

Bernstein and colleagues' specific research directly documented that glycolic acid treatment increases type I collagen mRNA and hyaluronic acid content in human skin — this represents direct, rigorous evidence that AHA use carries genuine structural benefit extending into dermal collagen and hyaluronic acid production, a barrier-adjacent structural benefit beyond simple corneocyte removal alone.^[2]

The Concentration-Dependent Barrier Consideration

Consistent with the broader over-exfoliation principle discussed extensively throughout this literature's barrier-damaging-habits reviews, AHA and BHA's genuine barrier-relevant risk emerges specifically at excessive concentration or frequency — exceeding the skin's natural desquamation and repair capacity produces net barrier compromise despite these acids' documented benefits at appropriately calibrated use.^[4]

Why Concurrent Barrier Support Matters

Rawlings and Harding's moisturization and skin barrier function research provides relevant context for understanding why concurrent ceramide-based barrier support matters specifically during AHA/BHA use — supporting the barrier through the transient disruption these acids' mechanism produces, consistent with the broader active-ingredient-and-barrier-relationship principle established throughout this literature.^[1]

BHA's Specific Considerations in Acne-Focused Use

Decker and Graber's review of over-the-counter acne treatments provides relevant, practically oriented context for BHA's specific barrier-relevant considerations within acne-focused use — reinforcing that BHA's oil-soluble mechanism, particularly relevant to pore-focused, sebum-adjacent application, carries its own distinct formulation and concentration considerations relative to AHA's more surface-focused mechanism.^[6]

Conclusion

AHA and BHA acids maintain a genuinely dual relationship with the skin barrier — providing documented structural benefit including measurable collagen and hyaluronic acid increases through their corneodesmosome-degradation mechanism, while carrying real, concentration-dependent barrier considerations at excessive use — supporting evidence-based, calibrated use combined with concurrent ceramide-based barrier support. For guidance calibrating AHA/BHA use for optimal barrier health, our pharmacist, Mine Ekber, is available for direct consultation via WhatsApp.

Frequently Asked Questions

Further Reading